Graham Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,368
Closed -$450K 1317
2025
Q1
$450K Sell
25,368
-3,913
-13% -$84.3K 0.01% 854
2024
Q4
$627K Buy
29,281
+13,958
+91% +$339K 0.01% 660
2024
Q3
$478K Buy
+15,323
New +$381K 0.01% 648
2022
Q4
Sell
-52,775
Closed -$898K 1073
2022
Q3
$898K Buy
+52,775
New +$1.13M 0.04% 531

Other funds holding CDNA

Graham Capital Management's CDNA Position: Q2 2025 in Review

Graham Capital Management sold out of CareDx (CDNA) in Q2 2025, closing a stake of 25,368 shares — an estimated $450K sold.

Graham Capital Management first reported a position in CDNA in Q3 2022 and held it in 4 quarters. The position peaked at $898K in Q3 2022. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Graham Capital Management reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Graham Capital Management sold 25,368 CareDx shares in Q2 2025, an estimated $450K.
  • Graham Capital Management first reported a position in CareDx in Q3 2022 and held it in 4 quarters.
  • Graham Capital Management's CareDx position peaked at $898K in Q3 2022.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.